Leukemia Research
Volume 30, Issue 6 , Pages 707-712 , June 2006

Clinical effects of oral green tea extracts in four patients with low grade B-cell malignancies

Received 1 August 2005 ,Revised 7 September 2005 ,Accepted 22 October 2005.

References 

  1. Yang C, Maliakal P, Meng X. Inhibition of carcinogenesis by tea. Annu Rev Pharmacol Toxicol. 2002;42:25–54
  2. Lee Y, Bone N, Strege A, Shanafelt T, Jelinek D, Kay N. VEGF receptor phosphorlyation status and apoptosis is modulated by a green tea component, epigallocatechin-3-gallate (EGCG), in B-cell chronic lymphocytic leukemia. Blood. 2004;104:788–794
  3. Kitada S, Andersen J, Akar S, et al. Expression of apoptotis-regulating proteins in chronic lymphocytic leukemia: correlations with in vitro and in vivo chemoresponses. Blood. 1998;91:3379–3389
  4. Saxena A, Viswanathan S, Moshynska O, Tandon P, Sankaran K, Sheridan D. Mcl-1 and Bcl-2/Bax ratio are associated with treatment response but not with Rai stage in B-cell chronic lymphocytic leukemia. Am J Hematol. 2004;75:22–33
  5. Yang CS. Inhibition of carcinogenesis by tea. Nature. 1997;389:134–135
  6. Cao Y, Cao R. Angiogenesis inhibited by drinking tea. Nature. 1999;398:381
  7. Yang CS, Chen L, Lee MJ, Balentine D, Kuo MC, Schantz SP. Blood and urine levels of tea catechins after ingestion of different amounts of green tea by human volunteers. Cancer Epidemiol Biomarkers Prev. 1998;7:351–354
  8. Ermakova S, Choi B, Choi H, Kang B, Bode A, Dong Z. The intermediate filament protein vimentin is a new target for EGCG. J Biol Chem. 2005;280:16882–16890
  9. Lin J. Cancer chemoprevention by tea polyphenols through modulating signal transduction pathways. Arch Pharm Res. 2002;25:561–575
  10. Cheson BD, Bennett JM, Grever M, et al. National Cancer Institute-Sponsored Working Group Guidelines for Chronic Lymphocytic Leukemia: revised guidelines for diagnosis and treatment. Blood. 1996;87:4990–4997
  11. News TESC. Green tea confuses cancer cells. CBS newscom; 2004. http://www.cbsnews.com/stories/2004/04/01/earlvshow/contributors/emilysenav/main609880.shtml.
  12. Harris NL, Jaffe ES, Diebold J, et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting—Airlie House, Virginia, November 1997. J Clin Oncol. 1999;17:3835–3849
  13. Cheson BD, Horning SJ, Coiffier B, et al. Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group. J Clin Oncol. 1999;17:1244
  14. Lamy S, Gingras D, Beliveau R. Green tea catechins inhibit vascular endothelial growth factor receptor phosphorylation. Cancer Res. 2002;62:381–385
  15. Jung Y, Kim M, Shin B, et al. EGCG, a major component of green tea, inhibits tumor growth by inhibiting VEGF induction in human colon carcinoma cells. Br J Cancer. 2001;84:844–850
  16. Ahmad N, Feyes DK, Nieminen AL, Agarwal R, Mukhtar H. Green tea constituent epigallocatechin-3-gallate and induction of apoptosis and cell cycle arrest in human carcinoma cells. J Natl Cancer Inst. 1997;89:1881–1886
  17. Naasani I, Oh-Hashi F, Oh-Hara T, et al. Blocking telomerase by dietary polyphenols is a major mechanism for limiting the growth of human cancer cells in vitro and in vivo. Cancer Res. 2003;63:824–830
  18. Naasani I, Seimiya H, Tsuruo T. Telomerase inhibition, telomere shortening, and senescence of cancer cells by tea catechins. Biochem Biophys Res Commun. 1998;249:391–396
  19. Navarro-Peran E, Cabezas-Herrera J, Garcia-Canovas F, Durrant M, Thorneley R, Rodriguez-Lopez J. The antifolate activity of tea catechins. Cancer Res. 2005;65:2059–2064
  20. Furukawa A, Oikawa S, Murata M, Hiraku Y, Kawanishi S. Epigallocatechin gallate causes oxidative damage to isolated and cellular DNA. Biochem Pharmacol. 2003;66:1769–1778
  21. Azam S, Hadi N, Khan N, Hadi S. Prooxidant property of green tea polyphenols epicatechin and epigallocatechin-3-gallate: implications for anti-cancer properties. Toxicol In Vitro. 2004;18:555–561
  22. Nakagawa H, Hasumi K, Woo J, Nagai K, Wachi M. Generation of hydrogen peroxide primarily contributes to the induction of FE(II) dependent apoptosis in Jurkat cells by epigallocatechin gallate. Carcinogenesis. 2004;25:1567–1574
  23. Nakazato T, Ito K, Ikeda Y, Kizaki M. Green tea component, catechin, induces apoptosis of human malignant B cells via production of reactive oxygen species. Clin Cancer Res. 2005;11:6040–6049
  24. Shammas MA, Koley H, Batchu R, et al. Specific killing of multiple myeloma cancer cells by epigallocatechin-3-gallate extracted from green tea. Blood. 2004;104:2461;[abstract]
  25. Malik A, Azam S, Hadi N, Hadi SM. DNA degradation by water extract of green tea in the presence of copper ions: implications for anticancer properties. Phytother Res. 2003;17:358–363
  26. Bertram B, Bollow U, Rajaee-Behbahani N, Burkle A, Schmezer P. Induction of poly(ADP-ribosyl)ation and DNA damage in human peripheral lymphocytes after treatment with (−)-epigallocatechin-gallate. Mutat Res. 2003;534:77–84
  27. Hayakawa F, Kimura T, Hoshino N, Ando T. DNA cleavage activities of (−)-epigallocatechin, (−)-epicatechin, (+)-catechin, and (−)-epigallocatechin gallate with various kinds of metal ions. Biosci Biotechnol Biochem. 1999;63:1654–1656
  28. Inoue M, Suzuki R, Koide T, Sakaguchi N, Ogihara Y, Yabu Y. Antioxidant, gallic acid, induces apoptosis in HL-60RG cells. Biochem Biophys Res Commun. 1994;204:898–904
  29. Jain A, Martin MC, Parveen N, Khan NU, Parish JH, Hadi SM. Reactivities of flavonoids with different hydroxyl substituents for the cleavage of DNA in the presence of Cu(II). Phytother Res. 1999;13:609–612
  30. Hadi SM, Asad SF, Singh S, Ahmad A. Putative mechanism for anticancer and apoptosis-inducing properties of plant-derived polyphenolic compounds. IUBMB Life. 2000;50:167–171
  31. Leone M, Zhai D, Sareth S, Kitada S, Reed JC, Pellecchia M. Cancer prevention by tea polyphenols is linked to their direct inhibition of antiapoptotic Bcl-2-family proteins. Cancer Res. 2003;63:8118–8121
  32. Nakazato T, Ito K, Miyakawa Y, et al. Catechin, a green tea component, rapidly induces apoptosis of myeloid leukemic cells via modulation of reactive oxygen species production in vitro and inhibits tumor growth in vivo. Haematologica. 2005;90:317–325
  33. Bettuzzi S, Brausi M, Rizzi F, Castagnetti G, Peracchia G, Corti A. Chemoprevention of human prostate cancer by oral administration of green tea catechins (GTCs) in high grade PIN subjects: a preliminary report from a 1 year proof of principle study. Proc Am Assoc Cancer Res. 2005;46:[abstract #4400]
  34. Chow H-HS, Cai Y, Hakim IA, et al. Pharmacokinetics and safety of green tea polyphenols after multiple-dose administration of epigallocatechin gallate and polyphenon E in healthy individuals. Clin Cancer Res. 2003;9:3312–3319
  35. Ullmann U, Haller J, Decourt J, et al. A single ascending dose study of epigallocatechin gallate in healthy volunteers. J Int Med Res. 2003;31:88–101
  36. Chow H, Hakim I, Vining D, et al. Effects of dosing condition on the oral bioavailability of green tea catechins after single-dose administration of polyphenon E in healthy adults. Proc Am Assoc Cancer Res. 2005;46:B70
  37. Pisters K, Newman R, Coldman B, et al. Phase I trial of oral green tea extract in adult patients with solid tumors. J Clin Oncol. 2001;19:1830–1838
  38. Thomas R, Ribeiro I, Shepherd P, et al. Spontaneous clinical regression in chronic lymphocytic leukaemia. Br J Haematol. 2002;116:341–345
  39. Gomez Garcia EB, van Lochem EG, van Lorn K, Hooijkaas H. Spontaneous remission of b-chronic lymphocytic leukaemia. Br J Haematol. 2002;119:874–875
  40. Ribera JM, Vinolas N, Urbano-Ispizua A, Gallart T, Montserrat E, Rozman C. “Spontaneous” complete remissions in chronic lymphocytic leukemia: report of three cases and review of the literature. Blood Cells. 1987;12:471–483

PII: S0145-2126(05)00421-2

doi: 10.1016/j.leukres.2005.10.020

Leukemia Research
Volume 30, Issue 6 , Pages 707-712 , June 2006

Article Tools

* Image Usage & Resolution